Cramer said the chart of this Brazil index shows its selloff in October produced the largest trading volume, and its more recent lows in November showing lighter volume. Since then, Cramer said shares have been slightly high, putting in higher and higher lows, a sign that buyers are growing more eager to buy and sellers less anxious to sell. But despite all of these good technical signs, Cramer said he's not a buyer. Brazil, he said, is a resource driven economy, and with commodity prices still plummeting, the fundamentals for Brazil are not pretty.

Cramer said he's a much bigger fan of China, with funds like the Xinhua China 25 Index (FXI). China has the strongest market in the world right now, up 6% for the year. The country is likely to put up to $1 trillion of stimulus to work, and Cramer said China isn't likely to fail in its endeavors.

According to the "technical" analysis, Cramer said Potash has bottomed and the chart is now turning bullish. Between Dec. 4 and Dec. 17, the stock rallied more than 60%, but instead of pulling back, it continued to rise another 5%, showing a lot of strength. He said it's clear investors have stopped selling into the rallies and the trend clearly changed for the stock back in October. But Cramer said he's not a technical investor, preferring to instead focus on the fundamentals. The fundamentals for Potash tell a similar story.

However even with the technicals and the fundamentals both showing strength, Cramer said he's not a buyer of Potash. Instead, he said he's a buyer of Terra Nitrogen (TNH), a stock he last recommended on Nov. 3 at $87.87 a share and a stock that's up 12.4%. Cramer said unlike Potash, Terra Nitrogen has everything going for it plus a great dividend to boot. It's the dividend, Cramer said, that makes Terra Nitrogen more reliable, and his choice for the fertilizer stock of choice. And with recent pullbacks, now is a perfect time to get in at a great price.

Conoco's oil production should increase in 2009, said Cramer, and with oil prices low, the company's refining business should also enjoy better margins. The company trades at only 7.1 times its earnings, while historically it should fetch a multiple of 9.2 times. Cramer's conclusion: the charts say "buy", but the fundamentals say "buy after Friday," when the company offers up its mid-quarter update.

According to the chartist, it's time to get out of biotech, said Cramer, as the IBB index has broken its trendline and appears to be headed sharply lower. But Cramer disagreed with the charts, saying the fundamentals tell another story.

The charts say sell, but the fundamentals look good to Cramer. Especially CELG, he said, the best and cheapest in the group.